Evidence map›Paper›PMID 40773075›Full record

ReviewDaru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences2025

New psychoactive substances: a multidisciplinary review of challenges and their diverse character.

Ilinca-Mihaela Marandiuc, Anca Oana Docea, Andreea Camelia Hîrjău, Oana Ruxandra Avram, Corina-Ștefania Matei, Aristidis Tsatsakis, Andreea-Letiția Arsene

Abstract readReview
In one paragraph

Review in Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ilinca-Mihaela MarandiucFaculty of Pharmacy, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania. ilinca-mihaela.marandiuc@drd.umfcd.ro.ORCID http://orcid.org/0009-0004-1277-0237
Anca Oana DoceaDepartment of Toxicology, Faculty of Pharmacy, University of Medicine and Pharmacy Craiova, Craiova, Romania. ancadocea@gmail.com.ORCID http://orcid.org/0000-0002-8162-5955
Andreea Camelia Hîrjău"Cantacuzino" National Institute for Medical-Military Research and Development, Bucharest, Romania.ORCID http://orcid.org/0009-0007-1538-0316
Oana Ruxandra Avram"Floreasca" Emergency Clinical Hospital, Bucharest, Romania.ORCID http://orcid.org/0009-0004-8601-0855
Corina-Ștefania Matei"Cantacuzino" National Institute for Medical-Military Research and Development, Bucharest, Romania.ORCID http://orcid.org/0000-0003-2964-7185
Aristidis TsatsakisFaculty of Pharmacy, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.ORCID http://orcid.org/0000-0003-3824-2462
Andreea-Letiția ArseneFaculty of Pharmacy, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.ORCID http://orcid.org/0000-0002-9478-6176

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNew psychoactive substances (NPS) pose a rapidly evolving public health challenge due to their diverse chemical structures and psychoactive effects, necessitating a comprehensive understanding of their classification, mechanisms of action, and detection.

objectivesRecognizing critical gaps in the understanding and management of NPS, this review aimed to synthesize current liter-ature. Specifically, we sought to elucidate the evolving classifications of NPS, delineate their underlying molecular mechanisms of action to inform therapeutic strategies, and critically evaluate existing detection methodologies to ad-dress current analytical limitations, thereby providing an essential, integrated perspective on this rapidly changing landscape.

methodsA narrative literature review was conducted to analyze NPS classification, molecular mechanisms, and detection techniques. Searches were performed across Web of Science, Scopus, PubMed, and Elsevier, using keywords such as "synthetic cathinones", "designer drugs", "new psychoactive substance(s)", "detection of new psychoactive sub-stances" and "toxicology." Inclusion criteria prioritized studies primarily focused on NPS with clearly defined com-pounds (e.g., UNODC, EMCDDA classifications) and published within the last four years. Eligible publications en-compassed in vivo and in vitro studies, original research, and various review types. Exclusion criteria involved liter-ature outside the specified timeframe and studies on established drugs of abuse or licit substances, unless a direct comparative analysis with NPS was presented.

resultsThe review synthesized a classification framework for NPS, detailed the molecular mechanisms underlying their psychoactive effects, and summarized current detection methodologies. Furthermore, it underscored the significant health risks associated with NPS use, including addiction, psychological disturbances, organ toxicity, and fatal outcomes.

conclusionThe continued emergence and proliferation of NPS necessitate ongoing research to fully characterize their specific effects and associated risks. This review provides a foundational synthesis of current knowledge, not only supporting the development of evi-dence-based interventions to mitigate their public health impact, but also serving as a catalyst for new research direc-tions aimed at a deeper understanding and more effective management of these evolving compounds.

Indexed as

Designer DrugsPsychotropic DrugsAnimalsHumansSubstance-Related DisordersDesigner DrugsPsychotropic DrugsDesigner drugsDrugs of abuseNew psychoactive substance(s)Risk assessment

Identifiers

PMID40773075
PMCPMC12331572

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.